Literature DB >> 28165563

HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition.

Y-X He1, X-H Song, Z-Y Zhao, H Zhao.   

Abstract

OBJECTIVE: In this study, we investigated the association between HOXA13 dysregulation and gastric cancer progression. We also explored the functional role of HOXA13 in invasion and epithelial-to-mesenchymal transition (EMT) of gastric cancer cells and the possible signaling pathway it might involve in.
MATERIALS AND METHODS: The microarray (E-GEOD-19826) examined the transcription profiles of 12 adjacent normal/tumor-matched gastric tissues was downloaded from the ArrayExpress and reanalyzed. Immunohistochemistry (IHC) staining was performed to assess HOXA13 expression in 23 stage I and 69 stage II/III/IV gastric cancer tissues. The human gastric cancer cell line AGS and SGC-7901 cells were transfected with HOXA13 siRNA and then were subjected to detection of epithelial and mesenchymal markers and cell invasion. The involvement of HOXA13 in TGF-β signaling was further studied.
RESULTS: HOXA13 is one of the most upregulated genes in gastric cancer tissues compared to adjacent normal tissues. Also, HOXA13 is further upregulated in the higher stage tumors. HOXA13 staining was significantly stronger in stage II/III/IV tumors than in stage I tumors. HOXA13 siRNA significantly restored the epithelial property and reduced the mesenchymal property of the cancer cells. Transwell assay showed that HOXA13 siRNA impaired the invasion capability of the cancer cells. The gastric cancer cells with HOXA13 knockdown had decreased expression of p-SMAD2 and p-SMAD3.
CONCLUSIONS: This study provides additional evidence about the association between HOXA13 upregulation and gastric cancer progression. Also, we showed that HOXA13 contributes to invasion and EMT of gastric cancer cells via the TGF-b signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28165563

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.784


  13 in total

1.  Bioinformatics analysis of potential Key lncRNA-miRNA-mRNA molecules as prognostic markers and important ceRNA axes in gastric cancer.

Authors:  Siqi Tang; Keyong Liao; Yongpeng Shi; Tingting Tang; Beibei Cui; Zunnan Huang
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

2.  Polycomb repression regulates Schwann cell proliferation and axon regeneration after nerve injury.

Authors:  Ki H Ma; Phu Duong; John J Moran; Nabil Junaidi; John Svaren
Journal:  Glia       Date:  2018-10-11       Impact factor: 7.452

3.  CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia.

Authors:  Athanasios Koulis; Natasha Di Costanzo; Catherine Mitchell; Stephen Lade; David Goode; Rita A Busuttil; Alex Boussioutas
Journal:  BMC Gastroenterol       Date:  2022-04-21       Impact factor: 2.847

4.  Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.

Authors:  Xiao Jin; Lu Dai; Yilan Ma; Jiayan Wang; Haihao Yan; Ye Jin; Xiaojuan Zhu; Zheng Liu
Journal:  BMC Cancer       Date:  2020-09-09       Impact factor: 4.430

5.  Elevated HOXA13 expression promotes the proliferation and metastasis of gastric cancer partly via activating Erk1/2.

Authors:  Zhiwei Qin; Zhengqian Chen; Junyong Weng; Shanbao Li; Zeyin Rong; Chongzhi Zhou
Journal:  Onco Targets Ther       Date:  2019-03-04       Impact factor: 4.147

6.  An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set.

Authors:  Melissa S DeRycke; Melissa C Larson; Asha A Nair; Shannon K McDonnell; Amy J French; Lori S Tillmans; Shaun M Riska; Saurabh Baheti; Zachary C Fogarty; Nicholas B Larson; Daniel R O'Brien; John C Cheville; Liang Wang; Daniel J Schaid; Stephen N Thibodeau
Journal:  PLoS One       Date:  2019-04-08       Impact factor: 3.240

7.  IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R.

Authors:  Chenyang Qiao; Wenjie Huang; Jie Chen; Weibo Feng; Tongyue Zhang; Yijun Wang; Danfei Liu; Xiaoyu Ji; Meng Xie; Mengyu Sun; Daiming Fan; Kaichun Wu; Limin Xia
Journal:  Cell Death Dis       Date:  2021-06-01       Impact factor: 8.469

8.  Effect of FOLFOX4 combined with Brucea javanica emulsion on VEGF in patients with gastric cancer.

Authors:  Zheng Chen; Zhenyu Zhou; Zhigang Hu; Qiaodong Xu; Jie Wang
Journal:  Oncol Lett       Date:  2017-11-16       Impact factor: 2.967

9.  Study of miR-10b regulatory mechanism for epithelial-mesenchymal transition, invasion and migration in nasopharyngeal carcinoma cells.

Authors:  Weiyi Wang
Journal:  Oncol Lett       Date:  2017-10-11       Impact factor: 2.967

10.  Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.

Authors:  Qi Shi; Luyan Shen; Bin Dong; Hao Fu; Xiaozheng Kang; Liang Dai; Yongbo Yang; Wanpu Yan; Ke-Neng Chen
Journal:  Thorac Cancer       Date:  2018-05-14       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.